Learn how human iPSC-derived sensory neurons can enhance your research by using an MEA system
Axol Human iPSC-Derived Sensory Neurons were cultured on a multiple-electrode array platform (Alpha MED Scientific) in order to investigate the potential of these cells to be used as an in vitro model that can recapitulate the sensation of human pain. This study showed that cultured Axol human iPSC-Derived Sensory Neurons display the typical characteristics and firing responses of human sensory neurons.
Neural organoid using the Bio 3D Printer Regenova (Cyfuse Biomedical K.K.)
Currently there are no definitive therapies for CNS (central nervous system) and spinal cord injuries. The aim of a neural organoid is to overcome limitations with current therapies and provide better solutions for a damaged human CNS or a spinal cord injury. A neural organoid might also be useful in conducting a neurotoxicity test for chemical agents.
Demonstration of 3D Culture of Axol hNPCs and hCCNs in a collagen gel using TAP Biosystems RAFT technology
The recapitulation of the complex microenvironment in which neural cells exists allows 3D culture systems to bridge the gap between traditional cell culture approaches and in vivo models such as transgenic mice. By mimicking the "stem cell niche" and physiological environments both mechanically and spatially, the crosstalk between the cells and environment leads to a closer scenario to what can be seen in the brain.
Study of neurite dynamics using Axol Human Neural Progenitor Cells using the IncuCyte NeuroTrack Platform
The study of neurite dynamics is elemental to the investigation of neuropathological disorders, neuronal injury and regeneration, embryonic development, and neuronal differentiation. Measurements of neurite dynamics are routinely used as a screening assay in neurotherapeutic drug discovery, and changes in neurite length and branching can predict neurotoxicity and neuroprotective effects induced by a compound.
Comparative transcriptome analysis of the expression profiles of iPS cells vs Axol human neural progenitor cells
Find the results of our comparative transcriptome analysis of the expression profiles of iPS cells vs Axol human neural progenitor cells. We provide links to the primary datasets on NCBI GEO and the summary plots of our findings.
Measuring Colony Forming Potential of Human iPSC-derived ECFCs in vitro
Measuring the colony forming potential of endothelial colony forming cells (ECFCs) is an excellent method for identifying the toxic effect of a compound on the proliferative potential of ECFCs.
Many disease pathologies are exacerbated by damage to blood vessels whereas increased vascularization encourages cancer progression and tumour growth, therefore there is an increased need for drugs that can alter the proliferative population of circulating ECFCs. This application note highlights the relevance and suitability for Human iPSC-Derived ECFCs in the investigation for compounds that target the anti- or pro-proliferative capabilities of ECFCs.
Three key points were covered in this study: Firstly, whether Axol Human iPSC-derived ECFCs were able to form colonies in vitro that hold a hierarchy of proliferative potentials equivalent to human primary cord blood ECFCs. Secondly, the in vitro colony forming potential of hiPSC-ECFCs was compared with human primary umbilical cord blood (CB) ECFCs. Finally, the application of ECFCs in a toxicity screen which identified the susceptible ECFC population.
Non-invasive impedance monitoring of contractility in Axol Human iPSC-Derived Cardiomyocytes
The ability to monitor cardiomyocyte beat rate in real time is a powerful tool for drug discovery research. To do this, human iPSC-derived cardiomyocytes (iPSC-CMs) were cultured in a non-invasive impedance monitoring system (xCELLigence®) to assess cardiotoxicity and cell contractility in a 96-well plate format.
Characterization of human iPSC-derived Macrophages reveals the hallmarks of macrophage morphology and function
The use of macrophages from peripheral blood or immortalized cell lines may be reducing the reproducibility and reliability of your disease research and its successful translation into new treatments.
The solution could be to use human induced pluripotent stem cell (hiPSC) - derived Macrophages. Their characterization has revealed that hiPSC-derived Macrophages are a functionally-validated, physiologically-relevant cellular model to benefit your anti-inflammatory and drug discovery research, as they have the typical morphological, molecular and functional hallmarks of human macrophages.